Bydureon (by-DUR-ee-on), a new long-acting form of Byetta (exenatide) for type 2 diabetes
You'll see Bydureon (by-DUR-ee-on), a new long-acting form of Byetta (exenatide) for type 2 diabetes.
Bydureon is injected just once a WEEK...compared to twice a day for Byetta or once a day for Victoza (liraglutide).
These glucagon-like peptide-1 (GLP-1) agonists are often added to oral meds to improve glycemic control and help patients lose weight.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote